DFX Intelligence

Data Factory

Private equityFirmhybrid manager · probableunsized

Balyasny Asset Management L.P.

Private Equity

Chicago, IL

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:25a6d898-ae0a-470b-9991-d2a4d5cf3b90

Data as of Sep 14, 2026 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 3:11 PM UTC and rebuilt at most every 15 minutes.

Relationships: 3
Dated events: 1
On other graphs: 3
Observed: Sep 13, 2026 to Sep 14, 2026
9 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Balyasny Asset Management L.P.

Venture manager · shared crd

Independent Sponsorsidentity

Balyasny Asset Management L.P.

Capital provider to sponsors · shared crd

RIA / Wealth Managementidentity

BALYASNY ASSET MANAGEMENT L.P.

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 0
PE funds: 0
Investments: 2
Active investments: 2
Size band: UNSIZEDderivedno Private Equity Fund GAV on a filing from 2021 or later

Investments

Company	State	Role	Control	Invested	Exited	Status
Coultreon Biopharma	n/a	minority	minority	Apr 28, 2026	n/a	active
Aspen Neuroscience	n/a	minority	minority	Nov 20, 2025	n/a	active

Relationships

Invested in (2)

→ Aspen NeuroscienceCompanyminority
Nov 20, 2025 to presentfactDFX's own graph
→ Coultreon BiopharmaCompanyminority
Apr 28, 2026 to presentfactDFX's own graph

Firm member (1)

→ HSI - Hemisfério Sul Investimentos LtdaFirmadviser
factDFX's own graph

Dated events

Occurred
Jan 23, 2006
New adviser on SEC roster
Balyasny Asset Management L.P. reports 3 Private Equity Fund(s) on its current Form ADV (Approved); not in the 2011-2024 extract
Form ADVobserved 5 days ago

Provenance

Graph: Private Equity
Canonical id: dfx:pe:25a6d898-ae0a-470b-9991-d2a4d5cf3b90
First observed: Sep 13, 2026
Last observed: Sep 14, 2026 5 days ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Balyasny Asset Management L.P.

Private Equity

Chicago, IL

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:25a6d898-ae0a-470b-9991-d2a4d5cf3b90

Data as of Sep 14, 2026 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 3:11 PM UTC and rebuilt at most every 15 minutes.

Company

State

Role

Control

Invested

Exited

Status

Coultreon Biopharma

n/a

minority

Apr 28, 2026

n/a

active

Aspen Neuroscience

n/a

minority

Nov 20, 2025

n/a

active